1. Cairat M, Al Rahmoun M, Gunter MJ, Severi G, Dossus L, Fournier A. Use of nonsteroidal anti-inflammatory drugs and breast cancer risk in a prospective cohort of postmenopausal women. Breast Cancer Res. 2020;22(1):118. [
DOI:10.1186/s13058-020-01343-1] [
PMID] [
PMCID]
2. da Costa Vieira RA, Biller G, Uemura G, Ruiz CA, Curado MP. Breast cancer screening in developing countries. Clinics (Sao Paulo). 2017;72(4):244-53. [
DOI:10.6061/clinics/2017(04)09]
3. Feng LY, Ou ZL, Wu FY, Shen ZZ, Shao ZM. Involvement of a novel chemokine decoy receptor CCX-CKR in breast cancer growth, metastasis and patient survival. Clin Cancer Res. 2009;15(9):2962-70. [
DOI:10.1158/1078-0432.CCR-08-2495] [
PMID]
4. Samarendra H, Jones K, Petrinic T, et al. A meta-analysis of CXCL12 expression for cancer prognosis. Br J Cancer. 2017;117(1):124-35. [
DOI:10.1038/bjc.2017.134] [
PMID] [
PMCID]
5. Parkes EE, Walker SM, Taggart LE, et al. Activation of sting-dependent innate immune signaling by S-phase-specific DNA damage in breast cancer. J Natl Cancer Inst. 2017;109(1). [
DOI:10.1093/jnci/djw199] [
PMID] [
PMCID]
6. Scala S. Molecular Pathways: Targeting the CXCR4-CXCL12 axis--untapped potential in the tumor microenvironment. Clin Cancer Res. 2015;21(19):4278-85. [
DOI:10.1158/1078-0432.CCR-14-0914] [
PMID]
7. Lee SY, Kim EK, Seo HB, et al. IL-17 induced stromal cell-derived factor-1 and profibrotic factor in keloid-derived skin fibroblasts via the STAT3 Pathway. Inflammation. 2020;43(2):664-72. [
DOI:10.1007/s10753-019-01148-1] [
PMID] [
PMCID]
8. Pavlasova G, Borsky M, Seda V, et al. Ibrutinib inhibits CD20 upregulation on CLL B cells mediated by the CXCR4/SDF-1 axis. Blood. 2016;128(12):1609-13. [
DOI:10.1182/blood-2016-04-709519] [
PMID] [
PMCID]
9. Takano T, Li YJ, Kukita A, et al. Mesenchymal stem cells markedly suppress inflammatory bone destruction in rats with adjuvant-induced arthritis. Lab Invest. 2014;94(3):286-96. [
DOI:10.1038/labinvest.2013.152] [
PMID]
10. Kobayashi K, Sato K, Kida T, et al. Stromal cell-derived factor-1alpha/C-X-C chemokine receptor type 4 axis promotes endothelial cell barrier integrity via phosphoinositide 3-kinase and Rac1 activation. Arterioscler Thromb Vasc Biol. 2014;34(8):1716-22. [
DOI:10.1161/ATVBAHA.114.303890] [
PMID]
11. Tong X, Ma Y, Deng H, et al. The SDF-1 rs1801157 polymorphism is associated with cancer risk: An update pooled analysis and FPRP test of 17,876 participants. Sci Rep. 2016;6:27466. [
DOI:10.1038/srep27466] [
PMID] [
PMCID]
12. Qin LF, Qin JM, Zhang JQ, Lv XP, Huang LY, Wang JJ. CXCL12 and CXCR4 polymorphisms and expressions in peripheral blood from patients of hepatocellular carcinoma. Future Oncol. 2018;14(13):1261-71. [
DOI:10.2217/fon-2017-0613] [
PMID]
13. Yu M, Berk R, Kosir MA. CXCL7-mediated stimulation of lymphangiogenic factors VEGF-C, VEGF-D in human breast cancer cells. J Oncol. 2010;2010:939407. [
DOI:10.1155/2010/939407] [
PMID] [
PMCID]
14. Okuyama N, Cezar dos Santos F, Paiva Trugilo K, Brajão de Oliveira K. Involvement of CXCL12 pathway in HPV-related diseases. AIMS Med Sci. 2016, 3(4): 417-40. [
DOI:10.3934/medsci.2016.4.417]
15. Saini V, Marchese A, Majetschak M. CXC chemokine receptor 4 is a cell surface receptor for extracellular ubiquitin. J Biol Chem. 2010;285(20):15566-76. [
DOI:10.1074/jbc.M110.103408] [
PMID] [
PMCID]
16. Guembarovski AL, Guembarovski RL, Hirata BKB, et al. CXCL12 chemokine and CXCR4 receptor: association with susceptibility and prognostic markers in triple negative breast cancer. Mol Biol Rep. 2018;45(5):741-50. [
DOI:10.1007/s11033-018-4215-7] [
PMID]
17. Bodelon C, Malone KE, Johnson LG, et al. Common sequence variants in chemokine-related genes and risk of breast cancer in post-menopausal women. Int J Mol Epidemiol Genet. 2013;4(4):218-27.
18. Sun Y, Mao X, Fan C, et al. CXCL12-CXCR4 axis promotes the natural selection of breast cancer cell metastasis. Tumour Biol. 2014;35(8):7765-73. [
DOI:10.1007/s13277-014-1816-1] [
PMID] [
PMCID]
19. de Oliveira KB, Guembarovski RL, Oda JM, Mantovani MS, et al. CXCL12 rs1801157 polymorphism and expression in peripheral blood from breast cancer patients. Cytokine. 2011;55(2):260-5. [
DOI:10.1016/j.cyto.2011.04.017] [
PMID]
20. Schimanski CC, Jordan M, Schlaegel F, et al. SNP rs1801157 significantly correlates with distant metastasis in CXCL12 expressing esophagogastric cancer. Int J Oncol. 2011;39(2):515-20. [
DOI:10.3892/ijo.2011.1044] [
PMID]
21. Chen R, Xu Y, Du X, et al. CXCL12 genetic variants as prognostic markers in nasopharyngeal carcinoma. Onco Targets Ther. 2015;8:2835-42. [
DOI:10.2147/OTT.S90430] [
PMID] [
PMCID]
22. Chang CC, Chen SC, Hsieh YH, et al. Stromal cell-derived factor-1 but not its receptor, CXCR4, gene variants increase susceptibility and pathological development of hepatocellular carcinoma. Clin Chem Lab Med. 2009;47(4):412-8. [
DOI:10.1515/CCLM.2009.092] [
PMID]
23. Lee YL, Kuo WH, Lin CW, et al. Association of genetic polymorphisms of CXCL12/SDF1 gene and its receptor, CXCR4, to the susceptibility and prognosis of non-small cell lung cancer. Lung Cancer. 2011;73(2):147-52. [
DOI:10.1016/j.lungcan.2010.12.011] [
PMID]
24. Yazdani Z, Mousavi Z, Moradabadi A, Hassanshahi G. Significance of CXCL12/CXCR4 ligand/receptor axis in various aspects of acute myeloid leukemia. Cancer Manag Res. 2020;12:2155-65. [
DOI:10.2147/CMAR.S234883] [
PMID] [
PMCID]
25. Falk D, Cubbin C, Jones B, Carrillo-Kappus K, Crocker A, Rice C. Increasing breast and cervical cancer screening in rural and border Texas with friend to friend plus patient navigation. J Cancer Educ. 2018;33(4):798-805. [
DOI:10.1007/s13187-016-1147-6] [
PMID] [
PMCID]
26. Okuyama Kishima M, Brajao de Oliveira K, Ariza CB, et al. Genetic polymorphism and expression of CXCR4 in breast cancer. Anal Cell Pathol (Amst). 2015;2015:289510. [
DOI:10.1155/2015/289510] [
PMID] [
PMCID]
27. Sharma GN, Dave R, Sanadya J, Sharma P, Sharma KK. Various types and management of breast cancer: an overview. J Adv Pharm Technol Res. 2010;1(2):109-26.
28. Seymour CB, Mothersill C. Breast cancer causes and treatment: where are we going wrong? Breast Cancer (Dove Med Press). 2013;5:111-9. [
DOI:10.2147/BCTT.S44399] [
PMID] [
PMCID]